Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07019519 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS

Study acronym: GA22
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 13, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study will describe the interplay between the gut hormones GIP and CCK and their regulation of blood flow to the large vessels in patients with Postural Orthostatic Tachycardia Syndrome (POTS) and GIP, CCK and GLP-1 in healthy. This is addressed by hormone infusions during MR-scans of the abdomen and intake of oral glucose.
Trial Details
NCT Number NCT07019519
Lead Sponsor University of Copenhagen
Collaborators: Rigshospitalet, Denmark
Conditions
(from sponsor)		 Postural Orthostatic Tachycardia Syndrome (POTS), Healthy
Related terms Postural Orthostatic Tachycardia Syndrome
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov